Definitive Contract 75A50122C00047
Award Date
8/29/22
Potential Completion Date
8/24/32
Potential Value
$630M
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27713, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract, valued at $131,992.00, was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit limited liability company that manufactures goods. The contract is for the delivery of "WET VAX SMALL POX" and was awarded on a firm fixed-price basis on May 1, 2019, with a completion date of August 31, 2019. The contract does not have a set-aside designation....
This contract award, valued at $37,890,000, was issued by the Centers for Disease Control and Prevention (CDC) to Emergent BioDefense Operations Lansing LLC for the delivery of ACAM 2000 vaccines. ACAM 2000 is the only Food and Drug Administration (FDA)-licensed vaccine for the prevention of smallpox disease, a critical component of the U.S. government's strategic national stockpile. The contract, awarded on September 30, 2015, is a firm-fixed-price delivery order with an ultimate completion...
This is a $1,403,362,669.10 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit limited liability company manufacturing medical countermeasures and pharmaceuticals. The contract, which has a period of performance through September 29, 2026, is for the development of filovirus treatments. Emergent has received over $1.3...
This is a $99,941,719.80 definitive, firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense, on March 16, 2017. The contract has an ultimate completion date of March 15, 2019 and is not set aside. Emergent Biodefense is a for-profit manufacturer of medical countermeasures and biopharmaceuticals, specializing in vaccines and therapeutics for public health...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit manufacturer of medical countermeasures. The $1,174,464,339.10 firm fixed-price contract is for the production of BioThrax, the only FDA-licensed vaccine for the prevention of anthrax disease, which is a critical component of the U.S. government's strategic national stockpile. The...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a Firm Fixed Price Purchase Order contract to Emergent Biodefense Operations Lansing LLC for the WETVAX 2021 project. The contract has a potential value of $141,400.00 and a completion date of August 31, 2021. The contract does not have a set-aside designation. Emergent Biodefense Operations Lansing LLC is the prime contractor for this award, which is likely related to the agency's...
This is a $918,380,272.80 definitive contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Phlow Corp, a for-profit pharmaceutical manufacturer, to provide U.S.-based advanced manufacturing of COVID-19 essential medicines and responses to future threats. The contract has a 10-year period of performance ending in May 2030 and uses a cost-plus-fixed-fee pricing structure. The award is funded under ASPR's...
This is a $19,763,563.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company and manufacturer of goods registered in the System for Award Management (SAM). The contract is part of the Centers for Innovation in Advanced...
This is a $31,006,981.93 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) for the development of an inhaled dry-powder formulation of the antiviral drug cidofovir. The contract is for the postexposure prophylaxis and treatment of smallpox and was not set aside for any special business designation. Resilience has previously performed other chemical,...
This is a federal contract award to Regeneron Pharmaceuticals Inc., a for-profit manufacturer of pharmaceuticals and therapeutics. The $692,086,314.00 award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract is for the development and production of "novel antibodies against influenza virus, emerging, re-emerging, and pre-emerging pathogens" under an Other...